Pro Share Advisors LLC Neoleukin Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.92 - $2.25 $10,110 - $24,727	-10,990 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$1.72 - $5.23 $4,578 - $13,922	-2,662 Reduced 19.5%	10,990 $20,000
Q4 2021 Feb 08, 2022	BUY	$4.65 - $7.75 $381 - $635	82 Added 0.6%	13,652 $67,000
Q3 2021 Nov 12, 2021	SELL	$6.05 - $9.66 $19,196 - $30,651	-3,173 Reduced 18.95%	13,570 $98,000
Q2 2021 Aug 13, 2021	BUY	$9.23 - $13.12 $21,524 - $30,595	2,332 Added 16.18%	16,743 $155,000
Q1 2021 May 14, 2021	BUY	$11.26 - $15.78 $9,109 - $12,766	809 Added 5.95%	14,411 $177,000
Q4 2020 Feb 09, 2021	BUY	$10.17 - $14.56 $138,332 - $198,045	13,602 New	13,602 $192,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.